In 2010 was created New Rhein Healthcare, which is appeared as VC. The venture was found in North America in United States. The main office of represented VC is situated in the Chicago.
Among the most popular portfolio startups of the fund, we may highlight Neuraptive Therapeutics, Biocartis, Chase Pharmaceuticals. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Medical Device, Medical.
The overall number of key employees were 3.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the New Rhein Healthcare, startups are often financed by Johnson & Johnson Development Corporation, Debiopharm Group, Aescap Venture. The meaningful sponsors for the fund in investment in the same round are Valiance Asset Management, RMM, Philips Venture Capital Fund. In the next rounds fund is usually obtained by PMV Tina Fund, Johnson & Johnson Development Corporation, Wellcome Trust.
The top amount of exits for fund were in 2016. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2018. Comparing to the other companies, this New Rhein Healthcare performs on 21 percentage points more the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.
Related Funds
Funds with similar focus
Fund Name | Location |
Aquitaine Creation | Aquitaine, France, Pessac |
Charter Venture Group | Houston, Texas, United States |
Ferry Venture Capital | China, Shanghai |
GCI Capital | Canada, Ontario, Toronto |
Genopole | Évry, France, Ile-de-France |
Joyvio Group | Beijing, Beijing, China |
Mapleblock Capital | - |
Singulariteam | Israel, Tel Aviv, Tel Aviv District |
Sleepz | Berlin, Berlin, Germany |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Corsair Pharma | $23M | 20 Sep 2023 | Sunnyvale, California, United States | ||
Theranica | $45M | 29 Aug 2022 | Israel, North District, Israel | ||
$7M | 06 Oct 2020 | Israel, North District, Israel | |||
American Injectables | $10M | 24 Sep 2020 | Tampa, Florida, United States | ||
Neuraptive Therapeutics | $11M | 19 Dec 2018 | Colorado, United States | ||
Neuraptive Therapeutics | $1M | 06 Sep 2017 | Colorado, United States | ||
Softhale | 30 Nov 2016 | Diepenbeek, Limburg, Belgium | |||
Chase Pharmaceuticals | $21M | 12 May 2014 | District of Columbia, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Corsair Pharma | $23M | 20 Sep 2023 | Sunnyvale, California, United States | ||
Theranica | $45M | 29 Aug 2022 | Israel, North District, Israel | ||
$7M | 06 Oct 2020 | Israel, North District, Israel | |||
American Injectables | $10M | 24 Sep 2020 | Tampa, Florida, United States | ||
Neuraptive Therapeutics | $11M | 19 Dec 2018 | Colorado, United States | ||
Neuraptive Therapeutics | $1M | 06 Sep 2017 | Colorado, United States | ||
Softhale | 30 Nov 2016 | Diepenbeek, Limburg, Belgium | |||
Chase Pharmaceuticals | $21M | 12 May 2014 | District of Columbia, United States |